Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05273060 · ClinicalTrials.gov registry record · NA
Regenerative Medicine Approach to Nasal Reconstruction
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT05273060: Completed NA study, sponsored by Mayo Clinic.
NCT05273060 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05273060, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this study is to gather information on the safety and effectiveness and compare nasal reconstruction standard planning versus 3D preoperative scanning/printing/planning.
Primary Outcome
Total number of subjects to have successful nasal reconstruction with transfer of viable tissue to reconstruct nasal defect
Interventions
- PROCEDURE 3D Nasal Reconstruction Planning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2022-05-18 |
| Est. Completion | 2024-12-19 |
| Phase | NA |
What the finished NCT05273060 record still lists
NCT05273060 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which 3D Nasal Reconstruction Planning is the first listed.
NCT05273060 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05273060 about?
NCT05273060 is a clinical study titled "Regenerative Medicine Approach to Nasal Reconstruction". The purpose of this study is to gather information on the safety and effectiveness and compare nasal reconstruction standard planning versus 3D preoperative scanning/printing/planning.
What is the current status of trial NCT05273060?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2022-05-18. Estimated completion is 2024-12-19.
What interventions are being tested in trial NCT05273060?
The interventions under investigation include: 3D Nasal Reconstruction Planning (PROCEDURE).
Who is sponsoring clinical trial NCT05273060?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05273060's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI